Cytotoxic T lymphocytes (CTL) play an important role in recovery from a number of viral infections. They are also implicated in virus-induced immunopathology, as best demonstrated in lymphocytic choriomeningitis virus (LCMV) infection of adult immunocompetent mice. In the present study, the structure of the T-cell receptor (TCR) in LCMV-specific CTL in C57BL/6 (B6) mice was investigated. Spleen T cells obtained from LCMV-infected mice were cultured in vitro with virus-infected stimulator cells and then stained with anti-TCR VP antibodies. A skewing of V, usage was noticeable in T cells enriched for their reactivity to LCMV, suggesting that particular V segments are important for the recognition of LCMV T-cell epitopes in B6 mice. To gain more detailed information on the structure of the TCR specific for LCMV epitopes, we studied CTL clones. It has been shown that approximately 90% of LCMV-reactive CTL clones generated in H-2b mice are specific for a short peptide fragment of the LCMV glycoprotein, residues 278 to 286, recognized in the context of the class I major histocompatibility complex molecule, Db. Four CTL clones possessing this specificity were randomly selected from a collection of clones, and their TCR genes were isolated by cDNA cloning or by the anchored polymerase chain reaction. All four clones were found to use V. gene segments belonging to the Va,4 subfamily. By RNA blot analysis, two more clones with the same specificity were also shown to express the Va4 mRNA. In contrast, three different V,, gene segments were used among the four clones examined. J,32.1 was used by three of the clones. Although amino acid sequences in the V(D)J junctional regions were dissimilar, aspartic acid was found in the Va.J and/or V,3D,J3 junctions of all four of these clones, suggesting that this residue is involved in binding the LCMV fragment. Restricted usage of V, and possibly J, segments in the CTL response to a major T-cell epitope of LCMV raises the possibility that immunopathology in LCMV infection can be treated with antibodies directed against such TCR segments. Thus, similar analysis of the TCR in other virus infections is warranted and may lead to therapeutic strategies for immunopathology due to virus infections.
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T cells recognize foreign antigen in the context of self major histocompatibility complex (MHC) molecules (58) . In general, cytotoxic T lymphocytes (CTL) recognize antigens in association with class I MHC molecules, whereas helper T cells see antigens associated with class II MHC molecules. The processed or degraded antigen peptides appear to be bound to MHC molecules in a groove between the a-helices of the polymorphic domains of MHC molecules (8, 9, 50) . The complex of a peptide fragment and an MHC molecule thus formed is recognized by a membrane-bound T-cell receptor (TCR) composed of ao and ,B chains (16) . The TCR at and 1B chains are encoded by discontinuous variable (V), diversity (D), joining (J), and constant (C) gene segments (13, 22, 42, 56) . The V, D, and J gene segments are rearranged during T-cell ontogeny to form a functional, continuous V-region gene, which is then posttranscriptionally spliced to C-region sequences. As with immunoglobulin genes, this mechanism of rearrangement in TCR genes can generate the high degree of receptor diversity required to recognize and respond to a virtually limitless universe of antigens (16) . Several groups have examined the relationship of TCR structure to function by characterizing the TCR sequences of T-cell clones and hybridomas with related antigen specificities. In some cases, such as for pigeon cytochrome c-specific clones, the majority of the T cells with the same antigen and MHC specificity were found to use the same a-and ,B-chain gene segments (19, 24, 54) . In the response to arsonate, most T cells use a particular a-chain V-gene segment (V,,a3), independent of the MHC restriction elements used (49) . In other cases, however, the TCR sequences are more heterogeneous (25, 46, 47) . On the basis of analysis of TCR sequences, intervention in the immune response has been attempted by using TCR-specific antibodies. For example, the vast majority of the T-cell clones causing autoimmune encephalomyelitis in PL and B10.PL mice were found to have the same V. and V,3 gene segments, and an antibody to the V. segment expressed by these T cells was successfully used to prevent the development of autoimmune encephalitis (1, 51) . A similar treatment, however, was not successful in a different strain of mouse (SJL), in which the response to myelin basic protein is more complex (43) .
In this report, the structure of the TCR in virus-specific CTL was studied. We chose the T-cell response to lympho-cytic choriomeningitis virus (LCMV) as a model system. LCMV is a member of the arenaviruses (bisegmented ambisense RNA viruses) (7) . The short (S) RNA encodes two major structural proteins, glycoprotein (GP) and nucleoprotein (NP), which are primarily responsible for induction of protective humoral (33) and cell-mediated (35) immunity. When the virus is injected intravenously or intraperitoneally, adult mice eliminate virus and recover. In contrast, when the virus is injected intracerebrally, the mice develop severe meningitis and ventriculitis and die 7 to 10 days later. Because death is attributable to the mouse's own vigorous cell-mediated immune response to virally infected leptomeningeal and ventricular cells, it can be prevented by immunosuppression (11, 29, 38) . Both virus clearance (immunity) and virus-induced immunopathology are mediated by CD8+ LCMV-specific class I MHC-restricted CTL (11, 57) . T-cell epitopes and restricting MHC molecules have been characterized in detail in the CTL response to LCMV (32, 45, 52, 53) , making this model system suitable for the study of TCR. Analysis of the TCR in virus-specific T cells should provide important information not only on the structure-function relationship of T-cell recognition but also on the potential for manipulation and abrogation of the harmful immune response to viral infections.
MATERIALS AND METHODS
Virus stock. The Armstrong CA1371 strain clone 53b (ARM) of LCMV was used for this study (17 CTL clones. Isolation and maintenance of LCMV-specific CTL clones used in this study were described previously (12, 32, 52 ).
Antibodies and cell staining. The following murine TCR V3-specific antibodies were used in these experiments: MR9-4 (V35), RR4-7 (VI36) (27) After in vitro culture, the spleen cells were depleted of B cells and stained with antibodies. The B-cell depletion was done by a panning method with a plate coated with antimouse immunoglobulin (55) . This method depleted more than 95% of B cells as revealed by fluorescence-activated cell sorter analysis. Some of the spleen cells were further stimulated weekly for another 3 weeks and in the presence of T-cell growth factor for the last 2 weeks. T-cell growth factor was prepared by treating Lewis rat lymphocytes with concanavalin A. CD8+ T cells were enriched from B-celldepleted spleen cells taken from uninfected mice by using the panning procedure described by Nikolic-Zugic and Bevan (31) .
cDNA library construction, isolation of TCR genes, and nucleotide sequencing. Cytoplasmic RNA was extracted from the T-cell clones, and double-stranded cDNA was synthesized from 10 p.g of total RNA by the method of Gubler and Hoffman (21) . The ends of cDNA were blunted with mung bean nuclease and the large fragment of DNA polymerase I (20) . cDNA larger than 500 bp possessing EcoRI linkers was ligated to EcoRI-digested A gtlO. After in vitro packaging, recombinants were plated onto a lawn of bacteria and screened with 32P-labeled DNA probes of TCR a-and ,B-chain C regions (25) (generously provided by T. W. Mak, Ontario Cancer Institute, Toronto, Canada). cDNA inserts of positive clones were isolated from A gtlO-cDNA recombinants and subcloned into a plasmid vector, pUC18. Nucleotide sequences of the cDNA inserts were determined by the dideoxy-chain termination method (44) .
Anchored polymerase chain reaction. The polymerase chain reaction (PCR) procedure described by Loh et al. (30) was followed with some modifications. The first-strand cDNA was synthesized from 10 ,ug of total RNA by using reverse transcriptase and oligo(dT) primer. [3H]dGTP was included in the reaction to trace the synthesis of the cDNA. To eliminate the oligo(dT) primer, which is inhibitory in the next step of the reaction (tailing), we electrophoresed cDNA/mRNA hybrids in low-melting-point agarose. cDNA/ mRNA hybrids greater than 500 bp were recovered from the gel, purified, and then precipitated in ethanol. A poly(dG) tail was added to the 3' end of the cDNA with terminal deoxynucleotidyltransferase (TdT) and dGTP (28) . [3H] dGTP was also included in the reaction to enable the length of the dG tail, which should be 10 to 20 G residues, to be ascertained. The product was then amplified by the PCR (40) by using the TCR C-region primer (C,a or C,3) and another oligonucleotide consisting of a poly(dC) tail attached to a sequence containing convenient restriction sites, termed the anchor (AN). The AN primer [without the attached poly(dC) tail] was also included to overcome the potential problem of generating progressively longer stretches of poly(dG)-poly(dC) with each cycle of the PCR (30) . The AN poly(C) primer (5'-CCTCGAGATCCTGCAGAATTCCCCCCCCCC CCCC-3') and the AN primer (5'-CCTCGAGATCCTGCA GAATTCC-3') contain XhoI, XhoII, PstI, and EcoRI restriction sites. The Ca primer (5'-GCTCGAGGATCTTTT AACTGGTACA-3') and the C,3 primer (5'-ACTCGAGTCA CATTTCTCAGATCCT-3') possess the XhoI site, which Structure of TCR in LCMV-specific CTL clones. To further characterize the structure of TCR involved in the recognition of LCMV, we randomly chose four LCMV-specific CTL clones, HL31, RG9, HL228, and HL39 (52), for the determination of TCR sequences. These clones are derived from three independent cloning experiments (HL31 and HL39 are derived from the same set of experiments) and were shown to have different patterns of gene rearrangement of the TCR ,B chain (26) . Reactivities of these clones have been reported previously (32, 52) and are summarized in Table 2 . All of the clones recognize the LCMV GP amino acid residues 278 to 286 in association with the class I MHC molecule, Db. It has been shown that approximately 90% of CTL clones generated in the H-2b haplotype are specific for this GP fragment and are restricted by Db (32, 52) . Although these clones are all specific for the same nine amino acid residues of GP, the reactivities to peptides with single-amino-acid substitutions at position 278 are different among these four clones (32) ( Table 2 ). HL228 failed to respond to target cells coated with the peptide having the valine 278-to-serine or threonine substitution, whereas the other clones retained the reactivity. The valine 278-to-phenylalanine substitution caused HL39 to lose its reactivity. All of the clones either lost VOL. 64, 1990 on January 27, 2018 by guest http://jvi.asm.org/ Downloaded from reactivity or had reduced reactivity to the peptide when valine 278 was substituted by tyrosine, aspartic acid, or glutamic acid.
A cDNA library was constructed from cytoplasmic RNA of HL228, and genes encoding TCR a and 3 chains were molecularly cloned. The TCR genes of the remaining CTL clones were obtained by using the anchored PCR (30) in which the first-strand cDNA was tailed by using TdT and oligo(dG) and then V-region genes were amplified by using oligo(dC) and TCR C-region primers. Nucleotide sequences of cloned TCR genes were determined and compared with the reported TCR sequences. At least three independent clones of each TCR gene were sequenced to verify nucleotide sequences and in-frame gene rearrangements. We found only one type of mRNA for each gene from all the CTL clones analyzed. The results are summarized in Table 3 . RG9 and HL228 share the same a-chain sequence, Va4.HL228, Ja.HL228 (Fig. 1) . Va4.HL228 has not been reported previously and has a 99.4% similarity at the nucleotide level to Va4.DA33 (47) . There are two nucleotide differences between these sequences, both of which lead to an amino acid substitution. Since no sequences of the corresponding genomic DNA are available, we cannot rule out the possibility that the differences are due to somatic mutations or allelic differences (even though T-cell clones from which the TCR genes were isolated are both derived from B6 mice). Ja.HL228 also has not been previously reported. HL31 and HL39 have the same Va (Va4.TA65) (3) , but use different Je, segments (3, 54) . Thus, all of the CTL clones examined here use gene segments belonging to the Va4 subfamily. In contrast, three different V,3 gene seg- (14) . Four of the five highly variable amino acid residues for 12 J. segments are shared by J.2.1 and J.2.6 (Fig. 2 ). J32.6 is missing alanine and has a conservative phenylalanine-to-tyrosine substitution in comparison with J32.1. Otherwise, J,32.1 and J42.6 are 362.1 is almost the same among the clones (HL31 has the junction one residue longer than the others), whereas the length of the VaJ, junctional region is more variable (up to a three-residue difference).
To confirm whether members of the Va4 subfamily are frequently used among CTL clones specific for the LCMV GP 278 to 286 epitope in the H-2b haplotype, we analyzed two more CTL clones with this specificity, HL232 and HL36 (26, 52) , for their Va usage by RNA blot analysis. These clones also expressed the Va4 mRNA like the four clones analyzed above, whereas other CTL clones specific for the LCMV NP and L', HD8, and HD32 (53), did not express the Va4 gene (Fig. 4) . VOL. 64, 1990 Jo.TA31, V38.1, and J.2.4 (34) (10, 25) , VaS (4), and Va8 (39) . Therefore, the Va4 segment itself cannot account for the specificity for Db. However, it is possible that the Db molecule complexed with the specific viral peptide, LCMV GP 278 to 286, forms a structure that best binds the Va4 segment. The four CTL clones examined had dissimilar amino acid sequences in the V(D)J junctional regions of their ot and P chains (Fig. 3) . This variability may be the molecular basis of the different reactivities of these four Va4+ CTL clones to LCMV GP 272 to 293 peptides with single-amino-acid substitutions at position 278 (Table 2) . Hedrick et al. have reported the presence of a highly selected junctional-region residue, found at position 100 of the P chain, in TCRs from pigeon cytochrome c-specific T-cell clones (23) . Using site-directed mutagenesis, they have also shown that this conserved amino acid residue plays a key role in determining the specificity for the antigenic peptide (18 
